The effect of endothelin-1 on nuclear factor kappa B in macrophages

S. H. Wilson, R. D. Simari, Amir Lerman

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Nuclear factor κB (NF-κB) is a transcriptional factor which may be pivotal in the pathogenesis of atherosclerosis. Endothelin-1 (ET-1) is a peptide with proatherogenic properties. We hypothesized that ET-1 may act through activation of NF-κB and degradation of IκB-α, the cytosolic inhibitor of NF-κB activation, to create an atherogenic environment. The human monocytic cell line THP-1 was stimulated with ET-1 ± the ET antagonist, BQ788 and the proteosome inhibitor, PSI. LPS was used as a positive control. Gel shift assays for NF-κB activity and Western blot analysis for IκB-α were performed. Both LPS and ET-1 led to activation of NF-κB in nuclear extracts [3.4 ± 0.45 (LPS) and 2.9 ± 0.26 (ET-1) fold increase in Arbitrary Densitometric Units (ADU) compared with negative control (P < 0.005 in both cases)]. In the presence of the ETB antagonist, BQ788, NF-κB activation was attenuated and not different from control (1.7 ± 0.24 fold DU compared with negative control; P = NS). In addition, both LPS and ET-1 mediated NF-κB activation were attenuated by preincubation with the proteosome inhibitor, PSI (1.3 ± 0.58 and 1.1 ± 0.3 fold increase in ADU compared with negative control respectively). Both LPS and ET-1 led to a decrease in the amount of IκB-α present in the THP-1 cytoplasmic extracts (2.1 ± 1.5% and 54 ± 15.7% of ADU vs negative control (P < 0.05). NF-κB is activated by ET-1 in human THP-1 monocytes. This data supports a role for the ETs in the development of inflammation in the vessel wall in atherosclerosis.

Original languageEnglish (US)
Pages (from-to)968-972
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume286
Issue number5
DOIs
StatePublished - 2001

Fingerprint

NF-kappa B
Macrophages
Endothelin-1
Chemical activation
Atherosclerosis
Corrosion inhibitors
Monocytes
Assays
Western Blotting
Gels
Cells
Inflammation
Cell Line
Degradation
Peptides

Keywords

  • Atherosclerosis
  • Endothelin
  • Inflammation
  • Monocytes

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

The effect of endothelin-1 on nuclear factor kappa B in macrophages. / Wilson, S. H.; Simari, R. D.; Lerman, Amir.

In: Biochemical and Biophysical Research Communications, Vol. 286, No. 5, 2001, p. 968-972.

Research output: Contribution to journalArticle

@article{bf6494d7a9e144a2a39dc793a45654de,
title = "The effect of endothelin-1 on nuclear factor kappa B in macrophages",
abstract = "Nuclear factor κB (NF-κB) is a transcriptional factor which may be pivotal in the pathogenesis of atherosclerosis. Endothelin-1 (ET-1) is a peptide with proatherogenic properties. We hypothesized that ET-1 may act through activation of NF-κB and degradation of IκB-α, the cytosolic inhibitor of NF-κB activation, to create an atherogenic environment. The human monocytic cell line THP-1 was stimulated with ET-1 ± the ET antagonist, BQ788 and the proteosome inhibitor, PSI. LPS was used as a positive control. Gel shift assays for NF-κB activity and Western blot analysis for IκB-α were performed. Both LPS and ET-1 led to activation of NF-κB in nuclear extracts [3.4 ± 0.45 (LPS) and 2.9 ± 0.26 (ET-1) fold increase in Arbitrary Densitometric Units (ADU) compared with negative control (P < 0.005 in both cases)]. In the presence of the ETB antagonist, BQ788, NF-κB activation was attenuated and not different from control (1.7 ± 0.24 fold DU compared with negative control; P = NS). In addition, both LPS and ET-1 mediated NF-κB activation were attenuated by preincubation with the proteosome inhibitor, PSI (1.3 ± 0.58 and 1.1 ± 0.3 fold increase in ADU compared with negative control respectively). Both LPS and ET-1 led to a decrease in the amount of IκB-α present in the THP-1 cytoplasmic extracts (2.1 ± 1.5{\%} and 54 ± 15.7{\%} of ADU vs negative control (P < 0.05). NF-κB is activated by ET-1 in human THP-1 monocytes. This data supports a role for the ETs in the development of inflammation in the vessel wall in atherosclerosis.",
keywords = "Atherosclerosis, Endothelin, Inflammation, Monocytes",
author = "Wilson, {S. H.} and Simari, {R. D.} and Amir Lerman",
year = "2001",
doi = "10.1006/bbrc.2001.5485",
language = "English (US)",
volume = "286",
pages = "968--972",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - The effect of endothelin-1 on nuclear factor kappa B in macrophages

AU - Wilson, S. H.

AU - Simari, R. D.

AU - Lerman, Amir

PY - 2001

Y1 - 2001

N2 - Nuclear factor κB (NF-κB) is a transcriptional factor which may be pivotal in the pathogenesis of atherosclerosis. Endothelin-1 (ET-1) is a peptide with proatherogenic properties. We hypothesized that ET-1 may act through activation of NF-κB and degradation of IκB-α, the cytosolic inhibitor of NF-κB activation, to create an atherogenic environment. The human monocytic cell line THP-1 was stimulated with ET-1 ± the ET antagonist, BQ788 and the proteosome inhibitor, PSI. LPS was used as a positive control. Gel shift assays for NF-κB activity and Western blot analysis for IκB-α were performed. Both LPS and ET-1 led to activation of NF-κB in nuclear extracts [3.4 ± 0.45 (LPS) and 2.9 ± 0.26 (ET-1) fold increase in Arbitrary Densitometric Units (ADU) compared with negative control (P < 0.005 in both cases)]. In the presence of the ETB antagonist, BQ788, NF-κB activation was attenuated and not different from control (1.7 ± 0.24 fold DU compared with negative control; P = NS). In addition, both LPS and ET-1 mediated NF-κB activation were attenuated by preincubation with the proteosome inhibitor, PSI (1.3 ± 0.58 and 1.1 ± 0.3 fold increase in ADU compared with negative control respectively). Both LPS and ET-1 led to a decrease in the amount of IκB-α present in the THP-1 cytoplasmic extracts (2.1 ± 1.5% and 54 ± 15.7% of ADU vs negative control (P < 0.05). NF-κB is activated by ET-1 in human THP-1 monocytes. This data supports a role for the ETs in the development of inflammation in the vessel wall in atherosclerosis.

AB - Nuclear factor κB (NF-κB) is a transcriptional factor which may be pivotal in the pathogenesis of atherosclerosis. Endothelin-1 (ET-1) is a peptide with proatherogenic properties. We hypothesized that ET-1 may act through activation of NF-κB and degradation of IκB-α, the cytosolic inhibitor of NF-κB activation, to create an atherogenic environment. The human monocytic cell line THP-1 was stimulated with ET-1 ± the ET antagonist, BQ788 and the proteosome inhibitor, PSI. LPS was used as a positive control. Gel shift assays for NF-κB activity and Western blot analysis for IκB-α were performed. Both LPS and ET-1 led to activation of NF-κB in nuclear extracts [3.4 ± 0.45 (LPS) and 2.9 ± 0.26 (ET-1) fold increase in Arbitrary Densitometric Units (ADU) compared with negative control (P < 0.005 in both cases)]. In the presence of the ETB antagonist, BQ788, NF-κB activation was attenuated and not different from control (1.7 ± 0.24 fold DU compared with negative control; P = NS). In addition, both LPS and ET-1 mediated NF-κB activation were attenuated by preincubation with the proteosome inhibitor, PSI (1.3 ± 0.58 and 1.1 ± 0.3 fold increase in ADU compared with negative control respectively). Both LPS and ET-1 led to a decrease in the amount of IκB-α present in the THP-1 cytoplasmic extracts (2.1 ± 1.5% and 54 ± 15.7% of ADU vs negative control (P < 0.05). NF-κB is activated by ET-1 in human THP-1 monocytes. This data supports a role for the ETs in the development of inflammation in the vessel wall in atherosclerosis.

KW - Atherosclerosis

KW - Endothelin

KW - Inflammation

KW - Monocytes

UR - http://www.scopus.com/inward/record.url?scp=0034805373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034805373&partnerID=8YFLogxK

U2 - 10.1006/bbrc.2001.5485

DO - 10.1006/bbrc.2001.5485

M3 - Article

VL - 286

SP - 968

EP - 972

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 5

ER -